Rare diseases
Investigational molecules
Locations
Back to France655 clinical trials in Clermont Ferrand, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine
FranceStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
FranceStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
FranceStudy of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment
FranceStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceFranceStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
FranceStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
FranceStudy Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer
FranceStudy on Sibeprenlimab for Patients with IgA Nephropathy
FranceStudy Comparing Balloon with Oxytocin and Oral Misoprostol for Inducing Labor in First-Time Mothers with Premature Rupture of Membranes at Term
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on inflammatory bowel diseases including groundbreaking trials examining fecal microbiota transplantation in both Crohn's disease and ulcerative colitis. Research aims to evaluate new therapeutic approaches for patients with moderate to severe conditions.
These trials are exploring alternative treatment pathways for patients who have not responded to conventional therapies.
Comprehensive research in multiple myeloma and various cancer types, including innovative treatments for esophageal squamous cell carcinoma and pleural mesothelioma. Studies evaluate new therapeutic combinations and maintenance strategies.
Focus on improving patient outcomes through targeted therapies and immunological approaches.
Advanced research into rheumatoid arthritis and multiple sclerosis, investigating optimized treatment protocols and maintenance therapies. Studies aim to improve long-term disease management and patient quality of life.
Emphasis on developing more effective and tolerable treatment regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
